Skip to main content
Premium Trial:

Request an Annual Quote

Kapa Biosystems, Roche NimbleGen Expand Agreement to Include Targeted RNA-seq Sample Prep

NEW YORK (GenomeWeb) − Kapa Biosystems will manufacture custom RNA-seq sample preparation kits for Roche NimbleGen under an expanded partnership, Kapa said today.

Specifically, Kapa will manufacture versions of its KAPA Stranded RNA-seq kits for distribution with Roche NimbleGen's recently launched SeqCap RNA target enrichment system.

Using both products, customers can start with as little as 10 nanograms of input RNA. The protocol allows for the precise measurement of strand orientation and mapping of alternate transcripts with high confidence, with uniform coverage and improved coverage of GC-rich and low-abundance transcripts, according to the companies.

The firms expanded their initial agreement from a year ago, under which Kapa custom-manufactures library prep kits for Roche NimbleGen's SeqCap EZ line of products.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.